2019 Update of Indian National Association for Study of the Liver Consensus on Prevention, Diagnosis, and Management of Hepatocellular Carcinoma in India: The Puri II Recommendations.
J Clin Exp Hepatol
; 10(1): 43-80, 2020.
Article
em En
| MEDLINE
| ID: mdl-32025166
AFP, alpha-fetoprotein; AIH, autoimmune hepatitis; ALT, alanine aminotransferase; DAA, direct-acting antiviral; DALY, disability-adjusted life-year; DNA, deoxyribonucleic acid; GRADE, Grading of Recommendations Assessment Development and Evaluation; Gd-BOPTA, gadolinium benzyloxypropionictetraacetate; Gd-EOB-DTPA, gadolinium ethoxybenzyl diethylenetriamine penta-acetic acid; HBV, hepatitis B virus; HBeAg, hepatitis B envelope antigen; HCC, hepatocellular carcinoma; HIV, human immunodeficiency virus; IARC, International Agency for Research on Cancer; IFN, interferon; INASL, Indian National Association for Study of the Liver; MiRNA, micro-RNA; NAFLD, non-alcoholic fatty liver disease; NASH, non-alcoholic steatohepatitis; PIVKA, protein induced by vitamin K absence; RFA; RNA, ribonucleic acid; SVR, sustained virological response; TACE; TACE, trans-arterial chemoembolization; TARE, transarterial radioembolization; TNF, tumor necrosis factor; WHO, World Health Organization; liver cancer; targeted therapy; transplant
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Tipo de estudo:
Diagnostic_studies
/
Guideline
/
Qualitative_research
/
Risk_factors_studies
Idioma:
En
Ano de publicação:
2020
Tipo de documento:
Article